Global Oncology Nutrition Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 1,974.75 Million |
 Market Size (Forecast Year) |
USD 3,630.83 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球肿瘤营养市场，按癌症类型（头颈癌、胃肠癌、食道癌、胰腺癌、肝癌、血癌、乳腺癌、肺癌等）、营养（肠内营养、肠外营养）、配方（标准配方、元素配方、专门配方）、给药途径（口服、肠外）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房）划分——行业趋势和预测到 2030 年。
肿瘤营养市场分析和规模
癌症发病率的上升是导致市场增长扩大的主要驱动力。影响肿瘤营养市场增长率的另一个重要因素是医疗保健支出的上升。此外，临床试验数量的增加、产品的快速开发和对肠内营养的关注度增加将缓冲肿瘤营养市场的增长率。此外，肿瘤患者营养研发活动的增加和新产品的推出将为 2023-2030 年预测期内的肿瘤营养市场提供有利的机会。此外，元素配方和新兴市场的发展将在未来提高全球肿瘤营养市场的增长率。
Data Bridge Market Research 分析称，全球肿瘤营养市场在 2022 年为 19.7475 亿美元，预计到 2030 年将达到 36.3083 亿美元，预计在 2023-2030 年预测期内的复合年增长率为 7.91%。这表明，由于技术的进步，头颈癌细分市场在全球肿瘤营养市场的癌症类型细分市场中占据主导地位。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
肿瘤营养市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
癌症类型（头颈癌、胃肠癌、食道癌、胰腺癌、肝癌、血癌、乳腺癌、肺癌、其他）、营养（肠内营养、肠外营养）、配方（标准配方、元素配方、特殊配方）、给药途径（口服、肠外）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
FMC Corporation (U.S.), Danone (India), Abbott (U.S.), Aceto (U.S.), B. Braun Melsungen AG (Germany),Baxter (U.S.), Fresenius Kabi AG (Germany),Global Health Products, Inc. (U.S.), Hormel Foods Corporation (U.S.), Mead Johnson & Company, LLC (U.S.), Meiji Holdings Co., Ltd (Japan), Nestlé S.A.( Switzerland), BioSig Technologies, Inc. (U.S.), Auris Health, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Cancer is characterised by the unregulated proliferation of aberrant cells. Tumor cells or malignant cells are the names given to these cells. Oncology is the branch of medicine that deals with the prevention, treatment and diagnosis of cancer. Oncology nutrition refers to the nutrition and diet that a cancer patient consumes during and after therapy. Nutrition is a crucial therapy during cancer treatment and plays a key influence in numerous aspects of cancer development. Appropriate diet can help cancer patients maintain a healthy weight and body composition, resulting in improved healing and a higher quality of life.
Global Oncology Nutrition Market Dynamics
Drivers
- Increasing Prevalence of Cancer
The rising incidence of cancer worldwide is a major driver for the global oncology nutrition market. Cancer patients often experience malnutrition and weight loss due to the disease itself or its treatments, creating a demand for specialized nutrition products.
- Growing Awareness of the Importance of Nutrition in Cancer Care
There is a growing recognition among healthcare professionals about the significant impact of nutrition on cancer treatment outcomes. This has led to increased emphasis on personalized nutrition plans for cancer patients, driving the demand for oncology nutrition products.
- Focus on Supportive Care in Cancer Management
Supportive care, including nutritional support, is an integral part of comprehensive cancer management. Oncology nutrition plays a crucial role in managing treatment-related side effects, improving quality of life, and enhancing treatment outcomes.
Opportunities
- Advancements in Cancer Treatments
Advancements in cancer treatments, such as chemotherapy, radiation therapy, and targeted therapies, have improved survival rates. However, these treatments can cause side effects like appetite loss, taste changes, and difficulty swallowing, creating a need for specialized nutrition support.
-
Rising Healthcare Expenditure
Increasing healthcare expenditure, particularly in emerging economies, has led to improved access to cancer treatments and supportive care services. This has contributed to the growth of the global oncology nutrition market.
Restraints/Challenges
- High Cost of Specialized Oncology Nutrition Products
Oncology-specific nutrition products can be expensive compared to regular nutritional supplements. The high cost may limit affordability and accessibility, particularly in lower-income regions, leading to restricted market growth.
-
Limited Reimbursement Coverage
In some healthcare systems, reimbursement coverage for oncology nutrition products may be limited or non-existent. This can pose challenges for patients and healthcare providers in accessing and utilizing these specialized products, affecting market growth
This global oncology nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global oncology nutrition market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- On July 2021, Nestlé Health Science, a leading player in the oncology nutrition market, announced the expansion of its portfolio with the launch of two new products: Resource® ThickenUp Clear Oncology and Resource ThickenUp Clear Oncology Ready-To-Drink. These products are designed to provide hydration and nutrition support for cancer patients with swallowing difficulties
- On June, 2021, Abbott, a global healthcare company, introduced ProSure Oncology in India. ProSure Oncology is a specialized nutritional supplement designed to support the nutritional needs of cancer patients undergoing treatment. It is formulated with high-quality protein, omega-3 fatty acids, and a blend of vitamins and minerals
Global Oncology Nutrition Market Scope
全球肿瘤营养市场根据癌症类型、营养和配方、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
癌症类型
- 头颈癌
- 胃和胃肠道癌症
- 食道癌
- 胰腺癌
- 肝癌
- 血癌
- 乳腺癌
- 肺癌
- 其他的
营养
- 肠内营养
- 肠外营养
公式
- 标准配方
- 元素配方
- 特殊配方
给药途径
- 口服
- 肠外
最终用户
- 医院
- 家庭护理
- 专科诊所
- 其他的
分销渠道
- 医院药房
- 网上药店
- 零售药店
全球肿瘤营养市场区域分析/见解
对全球肿瘤营养市场进行了分析，并按国家、癌症类型、营养、配方、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。
全球肿瘤营养市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美在全球肿瘤营养市场占据主导地位，因为该地区拥有强大的医疗设施基础、主要市场参与者的强大影响力、肿瘤营养产品的需求不断增长以及研究活动数量不断增加。
预计亚太地区将在 2023 年至 2030 年的预测期内出现显着增长，这得益于政府加强宣传力度、医疗旅游业兴起、该地区研究活动增多、拥有大量未开发市场、人口众多以及对优质医疗服务的需求不断增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
全球肿瘤营养市场还为您提供每个国家/地区资本设备医疗保健支出增长、全球肿瘤营养市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对全球肿瘤营养市场的影响的详细市场分析。数据适用于 2015-2020 年的历史时期。
竞争格局和全球肿瘤营养市场份额分析
全球肿瘤营养市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球肿瘤营养市场的关注有关。
全球肿瘤营养市场的一些主要参与者包括：
- FMC 公司 (美国)
- 达能（印度）
- 雅培（美国）
- Aceto（美国）
- B.Braun Melsungen AG（德国）
- 百特（美国）
- 费森尤斯卡比公司（德国）
- 全球健康产品公司（美国）
- 荷美尔食品公司（美国）
- 美赞臣公司（美国）
- 明治控股株式会社 (日本)
- 雀巢公司（瑞士）
- BioSig Technologies, Inc.（美国）
- Auris Health, Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
